THL Partners × Headlands Research
Private equity firm THL Partners entered a definitive agreement to acquire a majority stake in Headlands Research from the investment firm KKR. The deal values Headlands at approximately $600 million, according to sources familiar with the matter. One data aggregator reported a conflicting acquisition price of $1.2B, but the lower figure is more widely reported. KKR founded Headlands in 2018 to consolidate the fragmented clinical trial site industry.
The asset
A majority stake in Headlands Research, a multinational network of clinical trial sites, with the stated goal of enhancing its technology and infrastructure to deliver high-quality clinical trial data.
The record
- Seller status
- Going concern
- Sector
- Clinical trial site network
- Modalities
- clinical_trial_data
- Jurisdiction
- US
- Personal data
- Clinical trial data is subject to regulations such as HIPAA in the US, but specific PII handling for this transaction was not disclosed.
What it means if you hold data
This acquisition by a major private equity firm highlights the increasing value placed on the infrastructure that generates clinical trial data. The deal underscores a bet that demand for high-quality, diverse patient data will grow, driven by AI in drug discovery and a focus on including underrepresented populations in trials.